Ab initio molecular dynamics studies on HIV-1 reverse transcriptase triphosphate binding site: Implications for nucleoside-analog drug resistance

Protein Science

Volumn 9, Issue 12, 2000, Pages 2535-2546

  Alber, Frank ^a   Carloni, Paolo ^a,b  

^a SISSA   (Italy)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Ab initio molecular dynamics; Car Parrinello; HIV reverse transcriptase; Low barrier hydrogen bond; Mutations; Resistance

Indexed keywords

DIDANOSINE; LAMIVUDINE; NUCLEOSIDE ANALOG; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZALCITABINE; ZIDOVUDINE;

ARTICLE; DRUG SENSITIVITY; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME STRUCTURE; ENZYME SUBSTRATE; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROGEN BOND; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTON TRANSPORT; STRUCTURE ANALYSIS; X RAY ANALYSIS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0034493839     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.9.12.2535     Document Type: Article

References (79)

1. Conformational analysis of dimethyl phosphate in aqueous solution: A density-functional theory-based molecular dynamics study
2. Dimethyl phosphate: Stereoelectronic versus environmental effects
3. Density functional studies on herpes simplex virus type I thymidine kinase-substrate inter-actions: The role of Tyr-172 and Met-128 in thymine fixation
4. The K65R mutation confers increased DNA polymerase processivity to HIV-1 reverse transcriptase
5. HIV-1 reverse transcriptase: Structure predictions for the polymerase domain
6. Born-Oppenheimer molecular dynamics simulations of finite systems: Structure and dynamics
7. Density-functional exchange-energy approximation with correct asymptotic behaviour
8. A simple measure of electron localization in atomic and molecular systems
9. Molecular dynamics with coupling to an external bath
10. A theoretical study of torsional flexibility in the active site of aspartic proteinases: Implications for catalysis
11. A quantum mechanical study of the active site of aspartic proteinases
12. High-level resistance to (-) enantiomeric 2′-deoxy-3′-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase
13. Mutational analysis of the fingers and palm subdomain of human immunodeficiency virus type-1 (H1V-1) reverse transcriptase
14. Analysis of mutations at position 184 in reverse transcriptase of human immunodeficiency virus type 1
15. Unified approach for molecular dynamics and density-functional theory
16. Sensitivity of HIV-1 reverse transcriptase and its mutants to inhibition by azidothymidine triphosphate
17. Calculation of NH...pi hydrogen bond energies in basic pancreatic trypsin inhibitor
18. Human immunodeficiency virus reverse transcriptase. General properties and its interactions with nucleoside triphosphate analogs
19. Low-barrier hydrogen bonds and low fractionation factor bases in enzymatic reactions
20. Application of RESP charges to calculate conformational energies, hydrogen bond energies and free energies of solvation
21. HIV resistance to reverse transcriptase inhibitors
22. Serine proteases: An ab initio molecular dynamics study
23. HIV-1: Fifteen proteins and an RNA
24. The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2′,3′-dideoxyinosne and 2′,3′-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2′,3′-dideoxy-3′-thiacytidine
25. Factors contributing to the inhibition of HIV-reverse transcriptase by chain-terminating nucleotides in vitro and in vivo
26. The K65R mutant reverse transcriptase of HIV-1 cross-resistant to 2′, 3′-dideoxycytidine, 2′,3′-dideoxy-3′-thiacytidine, and 2′,3′-dideoxyinosine shows reduced sensitivity to specific dideoxynucleoside triphosphate inhibitors in vitro
27. Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2′,3′-dideoxycytidine and 2′,3′-dideoxy-3′-thiacytidine
28. Novel nucleoside strategies for anti-HIV and anti-HSV therapy
29. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: Implications for drug resistance
30. CPMD version 3.Oh; 1995-96
31. Electronic structure optimization in plane-wave-based density functional calculations by direct inversion in the iterative subspace
32. Multidrug-resistant human immunodeficiency virus type I strains resulting from combination antiretroviral therapy
33. Biochemical analysis of catalytically crucial aspartate mutants of human immunodeficiency virus type 1 reverse transcriptase
34. Fifth mutation in human immuno-deficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudíne
35. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures
36. Single-step kineties of HIV-1 reverse transcriptase mutants responsible for virus resistance to nucleoside inhibitors zidovudine and 3-TC
37. Inhibitors of HIV reverse transcriptase as antiviral agents and drug resistance
38. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)
39. Site-specific mutagenesis of AIDS virus reverse transcriptase
40. Closing in on HIV drug resistance
41. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density
42. Fractionation factors and activation energies for exchange of the low barrier hydrogen bonding proton in peptidyl trifluoromethyl ketone complexes of chymotrypsin
43. Mechanism of resistance of human immunodeficiency virus type 1 to 2′,3′-dideoxyinosine
44. The nature of the hydrated excess proton in water
45. Maximally localized generalized Wannier functions for composite energy bands
46. A mechanism of AZT resistance: An increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase
47. A unified formulation of the constant temperature molecular dynamics method
48. Model assembly study of the ligand binding by p-hydroxybenzoate hydroxylase: Correlation between the calculated binding energies and the experimental dissociation constants
49. Ab initio models for receptor-ligand inter-actions in proteins. 4. Model assembly study of the catalytic mechanism of triosephosphate isomerase
50. "Strong" hydrogen bonds in chemistry and biology
51. Conformational flexibility of the catalytic Asp dyad in HIV-1 protease: An ab initio study on the free enzyme
52. Convergence acceleration of iterative sequences. The case of SCF iteration
53. Endogenous reverse transcriptase assays reveal synergy between combinations of the M184V and other drug resistance-conferring mutations in interactions with nucleoside analog triphosphates
54. HIV drug resistance
55. Use of nitrogen-15 kinetic isotope effects to elucidate details of the chemical mechanism of human immuno-deficiency virus 1 protease
56. Touching the heart of HIV-1 drug resistance: The fingers close down on the dNTP at the polymerase active site
57. Competitive inhibitors of human immunodeficiency virus reverse transcriptase
58. On the electronic nature of low-barrier hydrogen bonds in enzymatic reactions
59. Emergence of human immuno-deficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides
60. Ab initio infrared spectrum of liquid water
61. Maximallylocalized Wannier functions for disordered systems: Application to amorphous silicon
62. Water molecule dipole in the gas and in the liquid phase
63. Structural, electronic, and bonding properties of liquid water from first principles
64. A classification of chemical bonds based on topological analysis of electron localization functions
65. Hydrogen-bonding in glycine and malonaldehyde: Performance of the Lap 1 correlation functional
66. Mutational analysis of Lys65 of HIV-1 reverse transcriptase
67. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance
68. A stereochemical rationale for the activity of the anti-HIV nucleosides
69. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase
70. Efficient pseudopotentials for plane-wave calculations
71. Structural Biology of HIV
72. GROMOS96, BIOMOS, biomolecular software b v
73. Raman difference studies of GDP and GTP binding to c-Harvey ras
74. Resistance to 2′,3′-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase